Literature DB >> 23592709

When 'digoxin use' is not the same as 'digoxin use': lessons from the AFFIRM trial.

Sabina A Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23592709     DOI： 10.1093/eurheartj/eht087

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  7 in total

1.  Opposing conclusions from post hoc analyses of the AFFIRM trial: was propensity score analysis to blame or just an innocent victim?

Authors:  Richard J Woodman
Journal:  Ther Adv Drug Saf       Date:  2014-02

2.  Beta-blockers or Digoxin for Atrial Fibrillation and Heart Failure?

Authors:  Laurent Fauchier; Guillaume Laborie; Nicolas Clementy; Dominique Babuty
Journal:  Card Fail Rev       Date:  2016-05

3.  Digoxin: A systematic review in atrial fibrillation, congestive heart failure and post myocardial infarction.

Authors:  Sebastiano Virgadamo; Richard Charnigo; Yousef Darrat; Gustavo Morales; Claude S Elayi
Journal:  World J Cardiol       Date:  2015-11-26

4.  Comparison between ivabradine and low-dose digoxin in the therapy of diastolic heart failure with preserved left ventricular systolic function.

Authors:  Giuseppe Cocco; Paul Jerie
Journal:  Clin Pract       Date:  2013-11-04

5.  Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.

Authors:  Alon Eisen; Christian T Ruff; Eugene Braunwald; Rose A Hamershock; Basil S Lewis; Christian Hassager; Tze-Fan Chao; Jean Yves Le Heuzey; Michele Mercuri; Howard Rutman; Elliott M Antman; Robert P Giugliano
Journal:  J Am Heart Assoc       Date:  2017-06-30       Impact factor: 5.501

Review 6.  Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data.

Authors:  Oliver J Ziff; Deirdre A Lane; Monica Samra; Michael Griffith; Paulus Kirchhof; Gregory Y H Lip; Richard P Steeds; Jonathan Townend; Dipak Kotecha
Journal:  BMJ       Date:  2015-08-30

7.  Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality.

Authors:  Rasmus Rivinius; Matthias Helmschrott; Arjang Ruhparwar; Ann-Kathrin Rahm; Fabrice F Darche; Dierk Thomas; Tom Bruckner; Philipp Ehlermann; Hugo A Katus; Andreas O Doesch
Journal:  Ther Clin Risk Manag       Date:  2017-10-13       Impact factor: 2.423
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.